Remed Co., Ltd. (CEO Ko Eun-hyun) announced that it will participate in the 3th International Medical Equipment & Hospital Equipment Exhibition ‘KIMES 23’ held at COEX, Seoul from March 26 (Thu) to 38 (Sun).
Remed is a company that has been manufacturing and supplying core parts related to medical devices and electrotherapy, focusing on the treatment of incurable brain diseases and non-invasive treatment for 17 years since its establishment. The company explains that it has achieved mutual growth with customers based on deep trust from the beginning of domestic major nerve modification technologies for Tibial Magnetic Stimulation (TMS), Nerve Magnetic Stimulation (NMS), and Core Strength Muscle Stimulation (CSMS) to the present. .
At this exhibition, Remed will showcase a large number of its own medical devices developed by itself. These products mainly consist of electromagnetic field and extracorporeal shock wave therapy devices for the treatment of musculoskeletal disorders, and ‘ALTMS’, a transcranial magnetic stimulation (TMS) medical device for the purpose of treating depression, will also be exhibited.
ALTMS is the first TMS device approved by the US FDA in Korea. To maximize convenience, a touch screen and one dial are installed, and there is no limit to the magnetic shot count, so there is no need for additional consumables.
At the same time, it can be used continuously for 24 hours with its own oil cooling system, supports Theta Burst (TBS) mode based on the 100Hz frequency specification, and can be linked with bioelectrical signals such as EMG. In addition, Remed is known to be continuing research and clinical trials to expand indications for the product.
Along with this, the medical devices that Remed will introduce at KIMES 2023 are ▲Salus-Talen-A, an electromagnetic field therapy device for musculoskeletal disorders and pain treatment ▲Salus-Talent-Pro, a two-channel electromagnetic field therapy device for musculoskeletal disorders and pain treatment ▲ ‘Salust-FSWT’, a Piezo-type digitally controlled focused extracorporeal shock wave therapy device, ▲ ‘Optimus-Pro’, a treatment device for incurable pain diseases using extracorporeal shock wave therapy and a powerful alternating electromagnetic field up to 2 Tesla.
An official from Remed said, “We decided to participate in the exhibition to show the direction of the company’s development with our new products and new technologies.” We will make it available for purchase,” he said.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.